{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:34:11Z","timestamp":1767904451884,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Dutch Thrombosis Foundation","award":["TSN 2009\u20131"],"award-info":[{"award-number":["TSN 2009\u20131"]}]}],"content-domain":{"domain":["internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.ijcard.2014.10.091","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T17:34:10Z","timestamp":1413999250000},"page":"105-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Plasma levels of soluble fibroblast activation protein in arterial thrombosis; determinants and cleavage of its substrate alpha-2-antiplasmin"],"prefix":"10.1016","volume":"178","author":[{"given":"Shirley","family":"Uitte de Willige","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce J.M.C.","family":"Malfliet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap W.","family":"Deckers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diederik W.J.","family":"Dippel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank W.G.","family":"Leebeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingeman C.","family":"Rijken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2014.10.091_bb0005","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/prca.201300095","article-title":"Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy","volume":"8","author":"Hamson","year":"2014","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.ijcard.2014.10.091_bb0010","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.biocel.2004.05.006","article-title":"Purification, identification and characterisation of seprase from bovine serum","volume":"36","author":"Collins","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ijcard.2014.10.091_bb0015","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2005-08-3452","article-title":"Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein","volume":"107","author":"Lee","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ijcard.2014.10.091_bb0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.abb.2006.11.006","article-title":"Effect of fibroblast activation protein and alpha(2)-antiplasmin cleaving enzyme on collagen types I, III, and IV","volume":"457","author":"Christiansen","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijcard.2014.10.091_bb0025","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1182\/blood-2003-12-4240","article-title":"A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion","volume":"103","author":"Lee","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ijcard.2014.10.091_bb0030","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1742-4658.2011.08051.x","article-title":"Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-alpha","volume":"278","author":"Keane","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.ijcard.2014.10.091_bb0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1034\/j.1600-0676.2002.01503.x","article-title":"Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection","volume":"22","author":"Levy","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.ijcard.2014.10.091_bb0040","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/jth.12396","article-title":"Increased N-terminal cleavage of alpha-2-antiplasmin in patients with liver cirrhosis","volume":"11","author":"Uitte de Willige","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2014.10.091_bb0045","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/eurheartj\/ehq519","article-title":"Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata","volume":"32","author":"Brokopp","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2014.10.091_bb0050","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1016\/j.ijcard.2013.06.061","article-title":"Circulating concentrations of fibroblast activation protein alpha in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA","volume":"168","author":"Tillmanns","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2014.10.091_bb0055","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1538-7836.2009.03350.x","article-title":"The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study","volume":"7","author":"de Bruijne","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2014.10.091_bb0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1050-3862(98)00019-9","article-title":"Allelic discrimination using fluorogenic probes and the 5\u2032 nuclease assay","volume":"14","author":"Livak","year":"1999","journal-title":"Genet. Anal."},{"key":"10.1016\/j.ijcard.2014.10.091_bb0065","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.10.091_bb0070","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.1158\/1078-0432.CCR-10-0119","article-title":"A combination of serum markers for the early detection of colorectal cancer","volume":"16","author":"Wild","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijcard.2014.10.091_bb0075","first-page":"1248","article-title":"A rare variant in human fibroblast activation protein associated with ER stress, loss of enzymatic function and loss of cell surface localisation","volume":"2014","author":"Osborne","year":"1844","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijcard.2014.10.091_bb0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fob.2013.12.001","article-title":"Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs","volume":"4","author":"Keane","year":"2013","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.ijcard.2014.10.091_bb0085","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1182\/blood-2007-01-065185","article-title":"The effect of a single nucleotide polymorphism on human {alpha}2-antiplasmin activity","volume":"109","author":"Christiansen","year":"2007","journal-title":"Blood"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314020282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314020282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T09:50:45Z","timestamp":1538128245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314020282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":17,"alternative-id":["S0167527314020282"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.10.091","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma levels of soluble fibroblast activation protein in arterial thrombosis; determinants and cleavage of its substrate alpha-2-antiplasmin","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.10.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}